Please Wait
Applying Filters...

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Lifordi is a biotechnology company pioneering the application of antibody–drug conjugate technology beyond oncology to treat autoimmune and inflammatory diseases. The company develops targeted therapies against myeloid and lymphoid cells and has demonstrated strong efficacy across multiple preclinical disease models. Backed by experienced immunology drug developers and funding from ARCH Venture Partners, 5AM Ventures, Atlas ...
Lifordi is a biotechnology company pioneering the application of antibody–drug conjugate technology beyond oncology to treat autoimmune and inflammatory diseases. The company develops targeted therapies against myeloid and lymphoid cells and has demonstrated strong efficacy across multiple preclinical disease models. Backed by experienced immunology drug developers and funding from ARCH Venture Partners, 5AM Ventures, Atlas Venture and Sanofi Ventures, Lifordi advances new approaches to immune and inflammatory disease treatment.

List your booth number for exhibitions, ask us